OMNIAB, INC. Cash and Restricted Cash
OMNIAB, INC. (OABI) had Cash and Restricted Cash of $24.90 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24.90M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $29.61M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $26.08M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $29.10M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $24.90M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $29.61M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $26.08M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $29.10M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $18.84M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $11.45M 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $28.16M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $27.80M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $21.35M 10-Q · filed 2025-08-06 | |
| 2024-03-31 | $19.62M 10-Q · filed 2025-05-08 | |
| 2023-12-31 | $16.92M 10-K · filed 2026-03-04 | |
| 2023-09-30 | $21.80M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $21.55M 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $23.31M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $33.84M 10-K · filed 2025-03-18 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | $19.85K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-10 | $159.19K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $434.63K 10-Q · filed 2022-05-20 |
| 2021-12-31 | $0.00 10-K · filed 2024-03-25 | $189.97K 10-K · filed 2022-03-28 |
| 2021-09-30 | $362.20K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $36.15K 10-Q · filed 2022-08-12 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-20 | |
| 2021-02-05 | $0.00 10-Q · filed 2022-08-12 | |
| 2021-02-04 | $0.00 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $0.00 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |